Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.
about
Corticosteroid implants for chronic non-infectious uveitisCorticosteroid implants for chronic non-infectious uveitisEmerging drugs for uveitisThe Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder CancerIntraocular Implants for the Treatment of Autoimmune UveitisThe therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacyAdvances in drug delivery to the posterior segmentManagement of noninfectious posterior uveitis with intravitreal drug therapyDrug delivery to the posterior segment of the eye for pharmacologic therapy.Current approach in the diagnosis and management of posterior uveitisThree-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.Single compartment drug delivery.Pharmacotherapy for uveitis: current management and emerging therapy.The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device.Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.Juvenile idiopathic arthritis-associated uveitis.Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomographyClinical trials in noninfectious uveitisUse of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population.Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusionSustained release intraocular drug delivery devices for treatment of uveitisBenefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and FollReservoir-based drug delivery systems utilizing microtechnology.Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) TrialLong-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis.Primed Mycobacterial Uveitis (PMU): Histologic and Cytokine Characterization of a Model of Uveitis in RatsOcular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE StudyDissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up StudyThe impact of macular edema on visual function in intermediate, posterior, and panuveitis.Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy.Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammationUveitic Macular Edema: Treatment Update.Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.Hydrodynamic Radii of Ranibizumab, Aflibercept and Bevacizumab Measured by Time-Resolved Phosphorescence Anisotropy.Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials.
P2860
Q24186144-4381E460-6979-4D05-A861-75EE46C0AE05Q24198202-2DCF2DC0-51B8-4CC8-99AD-5DA6454F5ABAQ24630848-59E01481-8DC2-4D9B-A7C2-84EDDB98637CQ26738516-01C321FD-50DA-4A57-8474-4DAC6243B32AQ26799168-0E7D7AFA-B1E1-49B7-A77F-C3CD106AF0A2Q26849299-0C91DB0F-BF99-4109-AA74-81EF64BB276CQ26995920-47C0B18C-7F1A-4BD6-A486-D499011D4704Q28074741-9E6E8855-B7A2-419B-8400-71AB0BE304BCQ30478379-033767F4-D2D6-498E-A3D4-C084DB4092DFQ30482534-AB93872F-3FED-4576-92FD-FA93F981F3A5Q33416368-C983A995-648E-43EC-8F88-8871F499FA7EQ34258708-D3980322-C812-4318-998C-DC9F19383CA8Q34263907-ECE54FC3-9160-4FA7-971E-0DD048D1632DQ34274075-9E2C95C0-1E29-44B3-AC0A-7663F616E73AQ34286402-FB2FEDF0-9C36-44D4-B169-47993896755FQ34630641-39891704-D1CC-40F7-AF24-8E7003E37272Q34786343-EE2397D1-0853-4B85-874C-FAE924633024Q34950552-AFAE1BE1-B06B-46CC-9185-AB630458371EQ35319079-29046A9B-4B1F-4C5B-ACAB-4155C87AA630Q35570770-1E10CC74-F1F1-499C-AE67-510572D4171DQ35681664-3275B3EF-6EEB-4949-8C4E-815212FD547EQ35752563-F50F99E2-21DB-49DC-B9B1-9088C0CAAEDCQ35794470-6702F97B-B233-4582-9C52-4DB21662FBCBQ35835614-344B214C-4F46-4CC5-BC37-146C01E3BC3BQ36090415-E54F8FC8-D65D-461D-A2B4-5BFE68A957FBQ36198990-FE033E26-14B0-4965-BD69-4B267B577FA8Q36218114-44A69D4B-FA5D-495C-B2CB-ED6D6B7414ECQ36310489-ADE5EF46-8A10-4903-BB4E-D37626D93DD9Q36407719-68E09A28-288B-42E8-A505-D51F97BF2EB7Q36424996-B7E70178-3A87-4111-8AB9-1F9B88640707Q36722548-2E05D43C-1D12-4648-8603-12F854640DA3Q36739472-D61F2DCE-B61B-4766-BCC1-99F2E695385DQ36814725-1AF6425C-A4DF-4B05-AC93-FEAB296EF873Q36929882-F91F4CAB-61E9-4B7C-953A-C6BCD3E549D6Q37017458-99C79A44-AE88-46FF-96C0-6AC0C0A9929FQ37029324-573E837C-0169-4FBE-A9BA-5B3B787CE523Q37038644-F2F08A8B-C3B0-4F1D-AFD7-0F38467D6D5EQ37088862-13565E96-A298-4393-BF61-F1BAF30068C4Q37188529-9BAAFD8D-D43F-4890-9112-A6BBB8CB2316Q37205804-90ABDC39-C1B5-4DC6-94E9-361F9FF017F4
P2860
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Treatment of posterior uveitis ...... e-year clinical trial results.
@en
type
label
Treatment of posterior uveitis ...... e-year clinical trial results.
@en
prefLabel
Treatment of posterior uveitis ...... e-year clinical trial results.
@en
P2093
P1433
P1476
Treatment of posterior uveitis ...... e-year clinical trial results.
@en
P2093
Daniel F Martin
David G Callanan
Glenn J Jaffe
P Andrew Pearson
Timothy L Comstock
P304
P356
10.1001/ARCHOPHT.126.9.1191
P407
P577
2008-09-01T00:00:00Z